Free Trial

Sharps Technology Q3 2023 Earnings Report

Sharps Technology logo
$0.03 0.00 (-6.40%)
As of 04/3/2025 04:00 PM Eastern

Sharps Technology EPS Results

Actual EPS
-$3.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Sharps Technology Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sharps Technology Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

Remove Ads

Sharps Technology Earnings Headlines

This almost killed Elon Musk (chilling details emerge)
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.
Sharps Technology issues letter to shareholders
See More Sharps Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sharps Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sharps Technology and other key companies, straight to your email.

About Sharps Technology

Sharps Technology (NASDAQ:STSS), a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

View Sharps Technology Profile

More Earnings Resources from MarketBeat